We have previously described the ability of Naphthoquinone-Tryptophan hybrids to inhibit the aggregation of PHF6 peptide in vitro and ameliorate the AD symptoms in transgenic Drosophila fly models expressing the human tau protein31,32. The gene discussed is MAPT; the disease is Alzheimer disease.